The stock of Petmed Express Inc (NASDAQ:PETS) hit a new 52-week high and has $40.97 target or 87.00% above today’s $21.91 share price. The 8 months bullish chart indicates low risk for the $452.62M company. The 1-year high was reported on Nov, 21 by Barchart.com. If the $40.97 price target is reached, the company will be worth $393.78 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 59,642 shares traded hands. Petmed Express Inc (NASDAQ:PETS) has risen 21.83% since April 19, 2016 and is uptrending. It has outperformed by 17.97% the S&P500.
Petmed Express Inc (NASDAQ:PETS) Ratings Coverage
Out of 2 analysts covering Petmed Express Inc (NASDAQ:PETS), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Petmed Express Inc has been the topic of 2 analyst reports since February 4, 2016 according to StockzIntelligence Inc. The rating was initiated by Credit Suisse on Thursday, February 4 with “Underperform”. The firm earned “Hold” rating on Monday, May 9 by Craig Hallum.
According to Zacks Investment Research, “Petmed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.”
Insitutional Activity: The institutional sentiment increased to 1.03 in 2016 Q2. Its up 0.15, from 0.88 in 2016Q1. The ratio improved, as 17 funds sold all Petmed Express Inc shares owned while 51 reduced positions. 19 funds bought stakes while 41 increased positions. They now own 14.80 million shares or 6.13% less from 15.76 million shares in 2016Q1.
Analytic Limited Liability Corp owns 221,891 shares or 0.05% of their US portfolio. North Star Invest Mgmt last reported 126,178 shares in the company. Vanguard Group Incorporated, a Pennsylvania-based fund reported 1.05 million shares. Lord Abbett & Ltd has 199,974 shares for 0.01% of their US portfolio. Schroder Inv Grp has 0.02% invested in the company for 417,711 shares. Moreover, Loring Wolcott & Coolidge Fiduciary Advsrs Ltd Liability Partnership Ma has 0% invested in Petmed Express Inc (NASDAQ:PETS) for 975 shares. Rhumbline Advisers last reported 57,444 shares in the company. Blackrock Group Incorporated Ltd holds 0% or 18,585 shares in its portfolio. Smithfield Tru has 290 shares for 0% of their US portfolio. Afam Cap, a Texas-based fund reported 102,012 shares. Acadian Asset Ltd Liability Com accumulated 79,038 shares or 0.01% of the stock. The New York-based Tiaa Cref Inv Management Ltd Liability has invested 0% in Petmed Express Inc (NASDAQ:PETS). Dekabank Deutsche Girozentrale holds 2,353 shares or 0% of its portfolio. Next Fincl Gp last reported 5,354 shares in the company. Blackrock Institutional Communications Na has 0% invested in the company for 557,050 shares.
Insider Transactions: Since August 8, 2016, the stock had 0 insider buys, and 9 selling transactions for $1.91 million net activity. AKDAG MENDERES also sold $865,000 worth of Petmed Express Inc (NASDAQ:PETS) shares. ROSENBLOOM BRUCE S sold $163,040 worth of Petmed Express Inc (NASDAQ:PETS) on Friday, August 12. SCHWEITZER ROBERT C also sold $61,755 worth of Petmed Express Inc (NASDAQ:PETS) shares. $217,500 worth of Petmed Express Inc (NASDAQ:PETS) was sold by FORMICA FRANK J on Wednesday, November 16.
More recent Petmed Express Inc (NASDAQ:PETS) news were published by: Quotes.Wsj.com which released: “News PetMed Express Inc.PETS” on February 12, 2011. Also Nasdaq.com published the news titled: “Earnings Reaction History: PetMed Express, Inc., 25.0% Follow-Through …” on October 24, 2016. Nasdaq.com‘s news article titled: “PetMed Express Inc. Reports 9% Advance In Q2 Bottom Line” with publication date: October 24, 2016 was also an interesting one.
PETS Company Profile
PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, incorporated on January 3, 1997, is a pet pharmacy. The Firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Firm offers a selection of products for dogs and cats. The Company’s product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.